GSK3B and Parkinson disease: Glycogen synthase kinase-3β (GSK-3β) is tightly related to the loss of dopaminergic neurons in PD models and MPP+-caused neuronal death (Golpich et al., 2015; Chen et al., 2017; Yue et al., 2017).